Skip to main content

Table 1 Demographics of the samples chosen for the study

From: Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer

Characteristics

Discovery cohort

External validation cohort

(n = 104)

(n = 84)

Median age at diagnosis in years (range)

50 (24 – 79)

54.5 (35 – 90)

Median follow up time from diagnosis in days (range)

2927.5 (170 – 6125)

1881.5 (174 – 3807)

Molecular subtypes

   Luminal A

62

51

   Luminal B

2

0

   Luminal B HER2

10

18

   Triple Negative

30

15

Menopausal status

   Pre

37

24

   Post

75

46

   Peri

11

3

   Unknown

1

11

Family history of Breast Cancer

   Yes

40

N/A

   No

58

N/A

   Unknown

6

N/A

Stage

  

   I

8

25

   II

79

47

   III

16

12

   IV

1

0

Overall Grade

   Low

36

N/A

   High

67

N/A

   Unknown

1

N/A

Vital Status

  

   Alive

58

57

   Dead

46

27

Relapse Status

Relapse

61

N/A

No relapse

43

N/A

Treatment type

   Adjuvant

79

84

   Neoadjuvant

25

0

  1. N/A = Not available